Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsy

Detalhes bibliográficos
Autor(a) principal: Dall'oglio,Marcos F.
Data de Publicação: 2005
Outros Autores: Crippa,Alexandre, Oliveira,Luis C., Neves Neto,Joao F., Leite,Katia R., Srougi,Miguel
Tipo de documento: Artigo
Idioma: eng
Título da fonte: International Braz J Urol (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382005000500005
Resumo: INTRODUCTION: The need for defining the extension of disease in patients undergoing radical prostatectomy due to prostate adenocarcinoma is a relevant factor cure in such individuals. In order to identify a new independent preoperative factor for predicting the extension of prostate cancer, we assessed the role of the percentage of positive fragments upon biopsy. MATERIALS AND METHODS: A retrospective study compared the percentage of positive fragments on biopsy with the extension of disease as defined by the pathological examination of the surgical specimen from 898 patients undergoing radical prostatectomy due to clinically localized prostate cancer. RESULTS: On the univariate analysis, the percentage of positive fragments on biopsy showed a statistical significance for predicting confined disease (p < 0.001), which was found in 66.7% of the cases under study. Additionally, we observed that the total number of removed fragments exerts no influence on the extension of the disease (p = 0.567). CONCLUSION: the percentage of positive fragments is an independent factor for predicting the pathological stage of prostate adenocarcinoma, and the number of removed fragments is not related to the extension of the disease.
id SBU-1_4a22065d5c24b5035a3e209e90c0c05b
oai_identifier_str oai:scielo:S1677-55382005000500005
network_acronym_str SBU-1
network_name_str International Braz J Urol (Online)
repository_id_str
spelling Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsyprostatic neoplasmsbiopsyneedleneoplasm stagingINTRODUCTION: The need for defining the extension of disease in patients undergoing radical prostatectomy due to prostate adenocarcinoma is a relevant factor cure in such individuals. In order to identify a new independent preoperative factor for predicting the extension of prostate cancer, we assessed the role of the percentage of positive fragments upon biopsy. MATERIALS AND METHODS: A retrospective study compared the percentage of positive fragments on biopsy with the extension of disease as defined by the pathological examination of the surgical specimen from 898 patients undergoing radical prostatectomy due to clinically localized prostate cancer. RESULTS: On the univariate analysis, the percentage of positive fragments on biopsy showed a statistical significance for predicting confined disease (p < 0.001), which was found in 66.7% of the cases under study. Additionally, we observed that the total number of removed fragments exerts no influence on the extension of the disease (p = 0.567). CONCLUSION: the percentage of positive fragments is an independent factor for predicting the pathological stage of prostate adenocarcinoma, and the number of removed fragments is not related to the extension of the disease.Sociedade Brasileira de Urologia2005-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382005000500005International braz j urol v.31 n.5 2005reponame:International Braz J Urol (Online)instname:Sociedade Brasileira de Urologia (SBU)instacron:SBU10.1590/S1677-55382005000500005info:eu-repo/semantics/openAccessDall'oglio,Marcos F.Crippa,AlexandreOliveira,Luis C.Neves Neto,Joao F.Leite,Katia R.Srougi,Migueleng2006-02-06T00:00:00Zoai:scielo:S1677-55382005000500005Revistahttp://www.brazjurol.com.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||brazjurol@brazjurol.com.br1677-61191677-5538opendoar:2006-02-06T00:00International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)false
dc.title.none.fl_str_mv Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsy
title Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsy
spellingShingle Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsy
Dall'oglio,Marcos F.
prostatic neoplasms
biopsy
needle
neoplasm staging
title_short Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsy
title_full Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsy
title_fullStr Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsy
title_full_unstemmed Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsy
title_sort Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsy
author Dall'oglio,Marcos F.
author_facet Dall'oglio,Marcos F.
Crippa,Alexandre
Oliveira,Luis C.
Neves Neto,Joao F.
Leite,Katia R.
Srougi,Miguel
author_role author
author2 Crippa,Alexandre
Oliveira,Luis C.
Neves Neto,Joao F.
Leite,Katia R.
Srougi,Miguel
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Dall'oglio,Marcos F.
Crippa,Alexandre
Oliveira,Luis C.
Neves Neto,Joao F.
Leite,Katia R.
Srougi,Miguel
dc.subject.por.fl_str_mv prostatic neoplasms
biopsy
needle
neoplasm staging
topic prostatic neoplasms
biopsy
needle
neoplasm staging
description INTRODUCTION: The need for defining the extension of disease in patients undergoing radical prostatectomy due to prostate adenocarcinoma is a relevant factor cure in such individuals. In order to identify a new independent preoperative factor for predicting the extension of prostate cancer, we assessed the role of the percentage of positive fragments upon biopsy. MATERIALS AND METHODS: A retrospective study compared the percentage of positive fragments on biopsy with the extension of disease as defined by the pathological examination of the surgical specimen from 898 patients undergoing radical prostatectomy due to clinically localized prostate cancer. RESULTS: On the univariate analysis, the percentage of positive fragments on biopsy showed a statistical significance for predicting confined disease (p < 0.001), which was found in 66.7% of the cases under study. Additionally, we observed that the total number of removed fragments exerts no influence on the extension of the disease (p = 0.567). CONCLUSION: the percentage of positive fragments is an independent factor for predicting the pathological stage of prostate adenocarcinoma, and the number of removed fragments is not related to the extension of the disease.
publishDate 2005
dc.date.none.fl_str_mv 2005-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382005000500005
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382005000500005
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1677-55382005000500005
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Urologia
publisher.none.fl_str_mv Sociedade Brasileira de Urologia
dc.source.none.fl_str_mv International braz j urol v.31 n.5 2005
reponame:International Braz J Urol (Online)
instname:Sociedade Brasileira de Urologia (SBU)
instacron:SBU
instname_str Sociedade Brasileira de Urologia (SBU)
instacron_str SBU
institution SBU
reponame_str International Braz J Urol (Online)
collection International Braz J Urol (Online)
repository.name.fl_str_mv International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)
repository.mail.fl_str_mv ||brazjurol@brazjurol.com.br
_version_ 1750318069427732480